LONDON, June 25, 2025 /PRNewswire/ -- Elsevier introduces Embase AI, a GenAI-powered version of Embase, the leading biomedical literature database. Embase AI transforms literature searches and other ...
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced an enhanced risk monitoring and pharmacovigilance solution with Embase, its ...
Data from studies conducted in more than 200 countries supports greater access to research and facilitates systematic reviews, clinical trial design, medical device approvals and improved drug safety ...
London 25 June 2025 – Elsevier introduces Embase AI, a GenAI-powered version of Embase, the leading biomedical literature database. Embase AI transforms literature searches and other tasks carried out ...
AMSTERDAM, Feb. 24, 2020 /PRNewswire/ -- Elsevier, a global leader in information analytics specializing in science and health, is making Embase, its biomedical database, available to Research4Life ...
DistillerSR's literature review platform to provide turn-key integrated access to Embase' API, greatly enhancing and simplifying the review process OTTAWA, ONTARIO / ACCESS Newswire / November 4, 2025 ...
London, 6 May 2025 – Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, ...
Embase AI addresses the need to simplify and enhance biomedical literature searches while increasing confidence in the results. The advanced solution expands access to biomedical data by giving users ...